• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Aldeyra Therapeutics Joins Oppenheimer Healthcare Life Sciences

    BUSINESSWIRE

    Aldeyra Extends Reproxalap Nda PDUFA For Dry Eye Disease

    BUSINESSWIRE

    Aldeyra Expands RASP to CNS Diseases, Updates Reproxalap

    BUSINESSWIRE

    Aldeyra Therapeutics Joins Jefferies Global Healthcare Conference

    BUSINESSWIRE

    Aldeyra Cans RASP Asset, Advances Two Pipeline Candidates

    BIOSPACE

    Aldeyra drops and swaps RASP assets in response to data

    BUSINESSWIRE

    Aldeyra Therapeutics to Present at H.C. Wainwright Conference

    PHARMAWEB

    Aldeyra Therapeutics Resubmits Reproxalap NDA for Dry Eye Disease

    BUSINESSWIRE

    Aldeyra Therapeutics at Jefferies Global Healthcare Conference

    BUSINESSWIRE

    Aldeyra Therapeutics Announces Phase 3 Dry Eye Trial Results

    BUSINESSWIRE

    Aldeyra Meets Ph 3 Endpoint with Reproxalap & Plans NDA Resubmission

    BUSINESSWIRE

    Aldeyra To Join 2025 Leerink Global Healthcare Conference

    BUSINESSWIRE

    Aldeyra Therapeutics to Present at Disruptive Innovations Symposium

    BUSINESSWIRE

    Aldeyra Files New Reproxalap Application For Dry Eye Disease

    BUSINESSWIRE

    Aldeyra Therapeutics to Join H.C. Wainwright Annual Global Investment Conference

    BUSINESSWIRE

    Aldeyra Therapeutics Achieves Primary Endpoint In Dry Eye Disease Trial

    BUSINESSWIRE

    Aldeyra Therapeutics Announces Next-Generation RASP-Modulator Drug Candidates Expected to Begin Clinical Trials for Systemic Immune-Mediated Diseases and Geographic Atrophy Review Highlights Growing Evidence That PharmaJet’s Precision Delivery Devices Improve Nucleic Acid Vaccine Performance

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.